Principal Investigator
Joshua Hare
Enrollment Status
Open
Clinical Trial ID
Institutional Protocol #
20260041
Clinical Trial Summary
A Phase 1/2 Multicenter, Open-Label, Dose-Escalation and Dose-Expansion Trial to Assess the Safety, Tolerability, Pharmacodynamics, and Preliminary Efficacy of AFTX-201 Administered to Adult Participants with BCL2-Associated Athanogene 3 (BAG3) Mutation-Associated Dilated Cardiomyopathy: UPBEAT Trial
Phase
TBD
Funding Agency/Sponsor
Industry
Disease
Other
Contact Information
Study Contact
Russell Saltzman
Phone Number
+1 (305) 243-1152
Email
r.saltzman@umiami.edu